arrow left
arrow right
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
						
                                

Preview

FILED: NEW YORK COUNTY CLERK 01/20/2022 01:52 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 659 RECEIVED NYSCEF: 01/20/2022 Exhibit OO September 4, 2018 Letter From Jerome T. Levy, Esq. To DOH (Without Enclosed Amended And Restated Plan Of Merger) Index No. 652343/2018 Motion Seq. No. 12 FILED: NEW YORK COUNTY CLERK 01/20/2022 01:52 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 659 RECEIVED NYSCEF: 01/20/2022 DuaneMorris SINGAPORE BALTIMORE PHILADELPHIA FIRMamlAFPTlJAIEOFFICES WILMINGTON CHICAGO MTAMI WASHINGTON,DC BOCARATON SANFRANCISCO PITTSBURGH JEROME T. LEVY SlL[CONVALLEY NEWARK DIRECT DIAL: +1 212 692 1013 SANplEGo PERSONAL FAX: +1 212 202 7596 LASVEGAS LOSANGELES JTLevy@duanemorris.com CHERRYHILL E-MAIL: TAIWAN LAKETAHOE BOSTON nqPtP.dt/anemorrirCOM MYANMAR HOUSTON OMAN AUSTIN OFF1CE AGCC12EPRESENTATIVE OfDUANKMORRIS HANOL ALLIANCESTNMEXTCO ANDSRTLANKA September 4, 2018 VIA EMAIL Nicole K. Quackenbush, Pharm.D, Director, Medical Marijuana Program New York State Department of Health Empire State Plaza, Corning Tower Albany, NY 12237 Re: Fiorello Inc. -- Pharmaceuticals, Amêñdcd Plan of Merger and Emuloyment Contracts Dear Ms. Quackenbush: To follow-up on my letter of August 31, 2018, I am enclosing herewith the Amended and Restated A greement and Plan of Merger which supersedes the document previously submitted to you. Also enclosed is a document highlighting the revisions from the previous agreement between the parties which were adopted as a result of our meeting with you and Department of Health personnel on August 28, 2018, You will note that the Amended Agreement adds an Exhibit C which will be employment agreements for Susan Yoss and Eric Sirota. Those agreements will be forwarded as soon as completed; we anticipate that they will be finalized within the next day or two. Please let me know if you have any questions, or if in any respect you believe that the enclosed amended agreement does not address satisfactorily the concerns expressed by the Department in our meeting. We hope that we can move quickly to allow the acceptance of the Amended Agreement, and GTI as the investor, so that Fiorello may move towards finalizing its leases for the dispensaries, and commencing construction of the grow facility. DUANE MORRIS LLP 540 BROADWAY NEW YORK, NY 10036-4086 PHONE: +1 212 692 1000FAX: +1 212 692 1020 DM2\918462Li . . - FILED: NEW YORK COUNTY CLERK 01/20/2022 01:52 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 659 RECEIVED NYSCEF: 01/20/2022 DuaneMorris Nicole K. Quackenbush, Pharm.D. September 4, 2018 Page 2 If you have any questions or concerns, please do not hesitate to communicate with me. Sincerely yours, 36rome T. bevy . .. JTL:mm Enclosures cc: Mr. Eric Sirota (Via Email) Ms. Susan Yoss (Via Email) Richard Zahnleuter, Esq. (Via Email) Ms. Jennifer Terrettblue (Via Email) Jason Riegert, Esq. (Via Email) Mr. Joshua Vinciguerra (Via Email) Michael Bass, Esq. (Via Email) DM2\9184621.1